咨询与建议

限定检索结果

文献类型

  • 248 篇 期刊文献
  • 4 篇 会议

馆藏范围

  • 252 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 108 篇 医学
    • 82 篇 临床医学
    • 57 篇 基础医学(可授医学...
    • 19 篇 药学(可授医学、理...
    • 8 篇 公共卫生与预防医...
  • 100 篇 理学
    • 62 篇 生物学
    • 12 篇 数学
    • 9 篇 物理学
    • 6 篇 化学
    • 5 篇 统计学(可授理学、...
    • 2 篇 天文学
  • 89 篇 工学
    • 36 篇 生物医学工程(可授...
    • 34 篇 计算机科学与技术...
    • 34 篇 软件工程
    • 29 篇 生物工程
    • 9 篇 光学工程
    • 6 篇 信息与通信工程
    • 4 篇 电气工程
    • 4 篇 电子科学与技术(可...
    • 3 篇 控制科学与工程
    • 3 篇 化学工程与技术
    • 2 篇 力学(可授工学、理...
    • 2 篇 材料科学与工程(可...
    • 2 篇 建筑学
    • 2 篇 土木工程
    • 2 篇 安全科学与工程
  • 27 篇 农学
    • 7 篇 作物学
  • 19 篇 管理学
    • 10 篇 管理科学与工程(可...
    • 5 篇 图书情报与档案管...
    • 4 篇 工商管理
    • 4 篇 公共管理
  • 2 篇 教育学
  • 1 篇 哲学

主题

  • 7 篇 pathology
  • 4 篇 cancer
  • 4 篇 diseases
  • 4 篇 tumors
  • 3 篇 computational bi...
  • 3 篇 machine learning
  • 3 篇 gene expression
  • 2 篇 human papillomav...
  • 2 篇 deep learning
  • 2 篇 generative adver...
  • 2 篇 image segmentati...
  • 2 篇 risk factors
  • 2 篇 cancer immunothe...
  • 2 篇 stage at diagnos...
  • 2 篇 genome-wide asso...
  • 2 篇 mortality
  • 2 篇 cervical cancer
  • 2 篇 epigenetic regul...
  • 2 篇 china
  • 2 篇 epigenetics

机构

  • 12 篇 cancer program b...
  • 11 篇 department of bi...
  • 11 篇 department of da...
  • 10 篇 department of in...
  • 10 篇 department of me...
  • 9 篇 department of bi...
  • 9 篇 dana-farber canc...
  • 8 篇 department of tw...
  • 8 篇 department of me...
  • 8 篇 department of pa...
  • 7 篇 institute for ca...
  • 7 篇 department of mo...
  • 7 篇 department of pa...
  • 7 篇 cancer data scie...
  • 7 篇 department of pa...
  • 7 篇 harvard medical ...
  • 7 篇 broad institute ...
  • 7 篇 data science pro...
  • 6 篇 national institu...
  • 6 篇 cancer program b...

作者

  • 25 篇 mahmood faisal
  • 20 篇 williamson drew ...
  • 19 篇 lu ming y.
  • 15 篇 chen tiffany y.
  • 14 篇 chen richard j.
  • 9 篇 jaume guillaume
  • 9 篇 lipkova jana
  • 8 篇 wei zheng
  • 7 篇 caroline hayward
  • 7 篇 song andrew h.
  • 6 篇 timothy m frayli...
  • 6 篇 danish saleheen
  • 6 篇 eleftheria zeggi...
  • 6 篇 mark i mccarthy
  • 6 篇 kari stefansson
  • 6 篇 macarthur daniel...
  • 6 篇 ezhov ivan
  • 6 篇 kofler florian
  • 6 篇 chen bowen
  • 6 篇 menze bjoern

语言

  • 245 篇 英文
  • 5 篇 其他
  • 2 篇 中文
检索条件"机构=Cancer Data Science Program"
252 条 记 录,以下是71-80 订阅
排序:
Gene set correlation enrichment analysis for interpreting and annotating gene expression profiles
收藏 引用
Nucleic Acids Research 2024年 第3期52卷 E17页
作者: Chang, Lan-Yun Lee, Meng-Zhan Wu, Yujia Lee, Wen-Kai Ma, Chia-Liang Chang, Jun-Mao Chen, Ciao-Wen Huang, Tzu-Chun Lee, Chia-Hwa Lee, Jih-Chin Tseng, Yu-Yao Lin, Chun-Yu Institute of Bioinformatics and Systems Biology National Yang Ming Chiao Tung University Hsinchu 300 Taiwan School of Medical Laboratory Science and Biotechnology College of Medical Science and Technology Taipei Medical University New Taipei City 235 Taiwan Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B) National Yang Ming Chiao Tung University Hsinchu 300 Taiwan TMU Research Center of Cancer Translational Medicine Taipei Medical University Taipei 110 Taiwan Ph.D. Program in Medical Biotechnology College of Medical Science and Technology Taipei Medical University New Taipei City 235 Taiwan Department of Otolaryngology-Head and Neck Surgery Tri-Service General Hospital National Defense Medical Center Taipei 110 Taiwan Department of Food Science Nutrition and Nutraceutical Biotechnology Shih Chien University Taipei 104 Taiwan Department of Biological Science and Technology National Yang Ming Chiao Tung University Hsinchu 300 Taiwan Cancer and Immunology Research Center National Yang Ming Chiao Tung University Taipei 112 Taiwan Institute of Data Science and Engineering National Yang Ming Chiao Tung University Hsinchu 300 Taiwan School of Dentistry Kaohsiung Medical University Kaohsiung 807 Taiwan
Pathway analysis, including nontopology-based (non-TB) and topology-based (TB) methods, is widely used to interpret the biological phenomena underlying differences in expression data between two phenotypes. By conside...
来源: 评论
PATHOLOGY RESIDENT EXPERIENCE USING A LOW-COST 3D PRINTED MICROSCOPE FOR PORTABLE DIGITAL PATHOLOGY
收藏 引用
Journal of Pathology Informatics 2022年 13卷 100043-100043页
作者: Williamson, Drew F.K. Chen, Tiffany Y. Mahmood, Faisal Department of Pathology Brigham and Women’s Hospital and Harvard Medical School Boston Massachusetts United States Cancer Program Broad Institute of Harvard and MIT Cambridge Massachusetts United States Department of Biomedical Informatics Harvard Medical School Boston Massachusetts United States Cancer Data Science Program Dana-Farber Cancer Institute Boston Massachusetts United States
来源: 评论
Development and Evaluation of a Process to Link cancer Patients in the SEER Registries to National Medicaid Enrollment data
收藏 引用
Journal of the National cancer Institute - Monographs 2020年 第55期2020卷 89-95页
作者: Warren, Joan L. Benner, Suzie Stevens, Jennifer Enewold, Lindsey Huang, Bin Zhao, Lirong Tilahun, Negussie Bradley, Cathy J. Healthcare Assessment Research Branch Healthcare Delivery Research Program Division of Cancer Control and Population Science National Cancer Institute Bethesda MD United States Fu Associates Ltd Arlington VA United States Information Management Services Calverton MD United States Department of Biostatistics College of Public Health Markey Cancer Center University of Kentucky Lexington KY United States Division of Data Research and Analytic Methods Center for Medicare and Medicaid Innovation Centers for Medicare and Medicaid Services Baltimore MD United States Department of Health Systems Management and Policy School of Public Health University of Colorado Aurora CO United States
cancer patients receiving Medicaid have worse prognosis. Patients in 14 Surveillance, Epidemiology, and End Results (SEER) cancer registries were linked to national Medicaid enrollment files, 2006-2013, to determine e...
来源: 评论
Deep learning-based computational pathology predicts origins for cancers of unknown primary
arXiv
收藏 引用
arXiv 2020年
作者: Lu, Ming Y. Zhao, Melissa Shady, Maha Lipkova, Jana Chen, Tiffany Y. Williamson, Drew F.K. Mahmood, Faisal Department of Pathology Brigham and Women’s Hospital Harvard Medical School BostonMA United States Department of Biomedical Informatics Harvard Medical School BostonMA United States Cancer Program Broad Institute of Harvard and MIT CambridgeMA United States Cancer Data Science Program Dana-Farber Cancer Institute BostonMA United States
cancer of unknown primary (CUP) is an enigmatic group of diagnoses where the primary anatomical site of tumor origin cannot be determined1,2. This poses a significant challenge, since modern therapeutics such as chemo... 详细信息
来源: 评论
Barriers to Allogeneic Stem Cell Transplant in Patients with Malignant and Non-Malignant Hematologic Conditions
收藏 引用
Transplantation and Cellular Therapy 2025年 第2期31卷 S359-S359页
作者: Burkart, Madelyn, MD Jabir, Abdur Rahman, MD Guasch, Sara Alicia, MD Isom, Scott, MS Jennings, Mrs. Rebecca, MSN, RN, BMTCN, OCN Grunwald, Michael Richard, MD Pang, Yifan, MD Howard, Dianna S., MD Wofford, Anne, MD Atrium health Wake Forest Baptist Comprehensive Cancer Center Winston Salem NC Department of Internal Medicine Atrium Health Wake Forest Baptist Medical Center Winston Salem NC Biostatistics and Data Science Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston Salem NC BMT Quality Atrium Health Wake Forest Baptist Winston Salem NC Department of Hematologic Oncology and Blood Disorders Atrium Health Levine Cancer Institute Charlotte NC Atrium Health Levine Cancer Institute Charlotte NC Stem Cell Transplant and Cellular Therapy Program Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston Salem NC Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston Salem NC
BackgroundAllogeneic stem cell transplant (HSCT) is a curative modality for many hematological conditions. Several advances have contributed to significant improvement of transplant accessibility including reduced int...
来源: 评论
AI-BASED FAST AND SCALABLE IMAGE SEARCH FOR RARE DISEASE DIAGNOSIS
收藏 引用
Journal of Pathology Informatics 2022年 13卷 100046-100046页
作者: Chen, Chengkuan Lu, Ming Y. Williamson, Drew F.K. Chen, Tiffany Y. Schaumberg, Andrew J. Mahmood, Faisal Department of Pathology Brigham and Women’s Hospital Harvard Medical School Boston MA USA Cancer Program Broad Institute of Harvard and MIT Cambridge MA USA Cancer Data Science Dana-Farber Cancer Institute Boston MA USA Department of Biomedical Informatics Harvard Medical School Boston MA USA
来源: 评论
Suboptimal Engraftment and Toxicity after Post-Transplant Cyclophosphamide
收藏 引用
Transplantation and Cellular Therapy 2025年 第2期31卷 S141-S142页
作者: Scarpetti, Lauren, MD Kim, Haesook T., PhD Ikeda, Daniel Collier, Kerry Chung, Jooho DeFilipp, Zachariah, MD El-Jawahri, Areej R., MD Frigault, Matthew J., MD McAfee, Steven L., MD Newcomb, Richard Andrew, MD Spitzer, Thomas R, MD Westervelt, Peter O'Donnell, Paul Chen, Yi-Bin, MD Hematopoetic Cell Transplant & Cell Therapy Program Massachusetts General Hospital Boston MA Department of Data Science Dana-Farber Cancer Institute Harvard School of Public Health Boston MA Massachusetts General Hospital Boston MA Hematopoietic Cell Transplant & Cell Therapy Program Massachusetts General Hospital Boston MA Hematopoietic Cell Transplant and Cellular Therapy Program Massachusetts General Hospital Boston MA Medicine Division of Hematology & Oncology Massachusetts General Hospital Boston MA Blood and Marrow Transplant Program Massachusetts General Hospital Boston MA Hematopoietic Cell Transplant and Cell Therapy Program Massachusetts General Hospital Boston MA
BackgroundPost-transplant cyclophosphamide (PTCy) after hematopoietic cell transplantation (HCT) to prevent graft-versus-host disease (GVHD) is increasingly considered standard. We conducted a single-center retrospect...
来源: 评论
Tumor-Intrinsic and Immune Predictors of Response to Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
收藏 引用
Blood 2024年 144卷 1928-1928页
作者: Michelle P. Aranha Omar Nadeem Robert A. Redd Michael Timonian Sophie Magidson Elizabeth D. Lightbody Jean-Baptiste Alberge Ting Wu Junko Tsuji Luca Bertamini Ankit K. Dutta Habib El-Khoury Mark Bustoros Jacob Laubach Giada Bianchi Elizabeth K. O'Donnell Kenneth C. Anderson Gad Getz Lorenzo Trippa Paul G. Richardson Irene Ghobrial Broad Institute of MIT and Harvard Cambridge MA Dana-Farber Cancer Institute Boston MA Harvard Medical School Boston MA Center for Early Detection and Interception of Blood Cancers Dana-Farber Cancer Institute Boston MA Department of Data Science Dana-Farber Cancer Institute Boston MA Division of Hematology & Medical Oncology Weill Cornell Medicine/New York Presbyterian Hospital New York NY Amyloidosis Program Division of Hematology Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA
Background Early treatment of patients with high-risk smoldering myeloma (HRSMM) has been shown to delay progression to multiple myeloma (MM), but not all patients respond well. Identifying biological predictors of re...
来源: 评论
A randomized phase 2 study of neratinib with or without fulvestrant for patients with HER2-positive, estrogen receptor-positive metastatic breast cancer
收藏 引用
Clinical Breast cancer 2025年
作者: Stefania Morganti Xiangying Chu Tarah J. Ballinger Nisha Unni Sarah Sinclair Robert Wesolowski Alyssa M. Pereslete Paulina Lange Nabihah Tayob Nancy U. Lin Jose P. Leone Ian E. Krop Sara M. Tolaney Heather A. Parsons Department of Medical Oncology Dana-Farber Cancer Institute Boston MA Breast Oncology Program Dana-Farber Brigham Cancer Center Boston MA Harvard Medical School Boston MA Broad Institute of MIT and Harvard Cambridge MA Data Science Dana-Farber Cancer Institute Boston MA Indiana University School of Medicine Indianapolis IN University of Texas Southwestern Medical Center Dallas TX Northern Light Cancer Care Brewer ME Department of Medicine The Ohio State University College of Medicine Columbus OH Florida International University Herbert Wertheim College of Medicine Miami FL Boston Medical Center Boston MA Yale Cancer Center New Haven CT
Background Most HER2-positive breast cancers co-express estrogen receptor (ER). Given crosstalk between HER2 and ER signaling pathways, dual blockade may be beneficial. Methods In this randomized, open-label, phase 2 ...
来源: 评论
Feasibility of Distress Thermometer Screening for Caregivers of Patients Undergoing Inpatient or Outpatient Hematopoietic Stem Cell Transplantation (HSCT)
收藏 引用
Transplantation and Cellular Therapy 2025年 第2期31卷 S493-S494页
作者: Gray, Tamryn Fowler, RN, PhD, MPH Heiling, Hillary, PhD Mazzola, Emanuele, PhD Amonoo, Hermioni Lokko, MD, MPP Sullivan, Lauren, MSN, RN, AGCNS-BC, OCN, BMTCN Kelkar, Amar H., MD, MPH, FACP Pirl, William, MD, MPH Hammer, Marilyn J. Tulsky, James A., MD El-Jawahri, Areej, M.D. Cutler, Corey S., MD MPH Partridge, Ann H., MD, MPH School of Nursing UNC Chapel Hill Chapel Hill NC Data Science Dana-Farber Cancer Institute Boston MA Dana-Farber Cancer Institute Boston MA Harvard Medical School Boston MA Commercial AbbVie North Chicago IL Department of Medical Oncology Dana-Farber Cancer Institute Boston MA Psychosocial Oncology and Palliative Care Dana-Farber Cancer Institute Boston MA Supportive Oncology Dana-Farber Cancer Institute Boston MA Medicine Division of Hematology & Oncology Massachusetts General Hospital Boston MA Department of Medical Oncology Dana-Farber Cancer Institute and Harvard Medical School Boston MA Division of Transplantation and Cellular Therapy Department of Medical Oncology Dana-Farber Cancer Institute Boston MA Stem Cell/Bone Marrow Transplantation Program Dana-Farber Cancer Institute Boston MA Division of Hematological Malignancies Department of Medical Oncology Dana Farber Cancer Institute Boston MA
Topic Significance & Study Purpose/Background/RationaleCaregivers of adults undergoing HSCT face considerable emotional challenges, yet few are screened for distress and limited data exists on whether caregiver di...
来源: 评论